Drugs not helping shift workers sleep well

Image
IANS London
Last Updated : Aug 13 2014 | 2:50 PM IST

The drugs that shift workers are taking to help them stay awake or get to sleep are not of much benefit and they may do more harm than good, says a review of available research.

"For lots of people who do shift work, it would be really useful if they could take a pill that would help them go to sleep or stay awake at the right time," said lead author of the review, Juha Liira, who is based at the Finnish Institute of Occupational Health in Helsinki, Finland.

"But from what we have seen in our review, there is not good evidence that these drugs can be considered for more than temporary use and some may have quite serious side effects," Liira added.

The review included 15 trials involving a total of 718 people. In nine trials, the over-the-counter hormone drug melatonin helped shift workers sleep for around 24 minutes longer during the night or day, compared to placebos.

However, it did not help them get to sleep any quicker.

Data from only one trial of the hypnotic drug zoplicone was available. The drug was no more effective than placebos for helping shift workers sleep during the day.

Modafinil and armodafinil, used by shift workers in one and two trials respectively, increased alertness and reduced sleepiness.

However, they also caused headaches, nausea and a rise in blood pressure in a substantial number of people.

The study appeared in Cochrane Reviews.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 13 2014 | 2:46 PM IST

Next Story